Trial Outcomes & Findings for OptiMesh® for Lumbar Interbody Fusion Trial (OLIF) (NCT NCT00764491)

NCT ID: NCT00764491

Last Updated: 2021-09-16

Results Overview

A Visual Analog Scale (VAS) score was used to evaluate a subject's level of pain. The VAS is a 10 cm pain scale where a score of "0" represents "No Pain" and a score of "10" represents the "Worst Possible" pain. The magnitude of change in the 24-month score compared to the baseline score is calculated. A clinically meaningful change is defined as a 2 unit (cm) reduction at 24-months when compared to pre-op.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

156 participants

Primary outcome timeframe

24 month

Results posted on

2021-09-16

Participant Flow

Participant milestones

Participant milestones
Measure
Optimesh 1500S
OptiMesh 1500S, filled with a mixture of demineralized bone matrix (DBM) and cortico-cancellous bone, placed into the interbody space from the posterior approach and supplemental pedicle screws. OptiMesh 1500S: Following disc space preparation the OptiMesh is deployed and filled in accordance with study surgical technique and supplemental instrumentation is provided as an adjunct to fixation.
Structural Allograft Spacer
Structural Allograft Spacer with pedicle screws. Structural Allograft Spacer: Following disc space preparation the spacer is placed in accordance with cleared labeling and supplemental instrumentation is provided as an adjunct to fixation.
Overall Study
STARTED
123
33
Overall Study
COMPLETED
88
16
Overall Study
NOT COMPLETED
35
17

Reasons for withdrawal

Reasons for withdrawal
Measure
Optimesh 1500S
OptiMesh 1500S, filled with a mixture of demineralized bone matrix (DBM) and cortico-cancellous bone, placed into the interbody space from the posterior approach and supplemental pedicle screws. OptiMesh 1500S: Following disc space preparation the OptiMesh is deployed and filled in accordance with study surgical technique and supplemental instrumentation is provided as an adjunct to fixation.
Structural Allograft Spacer
Structural Allograft Spacer with pedicle screws. Structural Allograft Spacer: Following disc space preparation the spacer is placed in accordance with cleared labeling and supplemental instrumentation is provided as an adjunct to fixation.
Overall Study
Lost to Follow-up
35
17

Baseline Characteristics

OptiMesh® for Lumbar Interbody Fusion Trial (OLIF)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Optimesh 1500S
n=123 Participants
OptiMesh 1500S, filled with a mixture of demineralized bone matrix (DBM) and cortico-cancellous bone, placed into the interbody space from the posterior approach and supplemental pedicle screws. OptiMesh 1500S: Following disc space preparation the OptiMesh is deployed and filled in accordance with study surgical technique and supplemental instrumentation is provided as an adjunct to fixation.
Structural Allograft Spacer
n=33 Participants
Structural Allograft Spacer with pedicle screws. Structural Allograft Spacer: Following disc space preparation the spacer is placed in accordance with cleared labeling and supplemental instrumentation is provided as an adjunct to fixation.
Total
n=156 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
104 Participants
n=5 Participants
29 Participants
n=7 Participants
133 Participants
n=5 Participants
Age, Categorical
>=65 years
19 Participants
n=5 Participants
4 Participants
n=7 Participants
23 Participants
n=5 Participants
Age, Continuous
51.18 Years
STANDARD_DEVIATION 12.19 • n=5 Participants
53.91 Years
STANDARD_DEVIATION 10.81 • n=7 Participants
51.76 Years
STANDARD_DEVIATION 11.93 • n=5 Participants
Sex: Female, Male
Female
57 Participants
n=5 Participants
15 Participants
n=7 Participants
72 Participants
n=5 Participants
Sex: Female, Male
Male
66 Participants
n=5 Participants
18 Participants
n=7 Participants
84 Participants
n=5 Participants
Region of Enrollment
United States
123 participants
n=5 Participants
33 participants
n=7 Participants
156 participants
n=5 Participants

PRIMARY outcome

Timeframe: 24 month

Population: A total of 88 investigational and 16 control subjects completed this question at the 24-month timepoint.

A Visual Analog Scale (VAS) score was used to evaluate a subject's level of pain. The VAS is a 10 cm pain scale where a score of "0" represents "No Pain" and a score of "10" represents the "Worst Possible" pain. The magnitude of change in the 24-month score compared to the baseline score is calculated. A clinically meaningful change is defined as a 2 unit (cm) reduction at 24-months when compared to pre-op.

Outcome measures

Outcome measures
Measure
Optimesh 1500S
n=88 Participants
OptiMesh 1500S, filled with a mixture of demineralized bone matrix (DBM) and cortico-cancellous bone, placed into the interbody space from the posterior approach and supplemental pedicle screws. OptiMesh 1500S: Following disc space preparation the OptiMesh is deployed and filled in accordance with study surgical technique and supplemental instrumentation is provided as an adjunct to fixation.
Structural Allograft Spacer
n=16 Participants
Structural Allograft Spacer with pedicle screws. Structural Allograft Spacer: Following disc space preparation the spacer is placed in accordance with cleared labeling and supplemental instrumentation is provided as an adjunct to fixation.
Mean Change in Low Back Pain Score at 24-months Compared to Pre-op
-4.0 units on a scale
Standard Error 0.57825
-4.0 units on a scale
Standard Error 1.50207

PRIMARY outcome

Timeframe: 24 month

Population: A total of 88 investigational and 16 control subjects completed the ODI questionnaire at the 24-month timepoint.

A subject's back function was assessed by the Oswestry Disability Index (ODI). The ODI is a 10 question survey that evaluates the degree of functional impairment. Completion of the survey yields a score from "0" to "100" points. A score of "0" represents "No disability" and "100" represents "Total disability". The magnitude of change between the two timepoints is reported. A clinically meaningful improvement is defined as a 15 point reduction at 24-months compared to the pre-op score.

Outcome measures

Outcome measures
Measure
Optimesh 1500S
n=88 Participants
OptiMesh 1500S, filled with a mixture of demineralized bone matrix (DBM) and cortico-cancellous bone, placed into the interbody space from the posterior approach and supplemental pedicle screws. OptiMesh 1500S: Following disc space preparation the OptiMesh is deployed and filled in accordance with study surgical technique and supplemental instrumentation is provided as an adjunct to fixation.
Structural Allograft Spacer
n=16 Participants
Structural Allograft Spacer with pedicle screws. Structural Allograft Spacer: Following disc space preparation the spacer is placed in accordance with cleared labeling and supplemental instrumentation is provided as an adjunct to fixation.
Mean Change in Back Function Score at 24-months Compared to Pre-op
-21.6 score on a scale
Standard Error 4.4055
-18.4 score on a scale
Standard Error 9.8028

PRIMARY outcome

Timeframe: 24 month

Population: A total of 77 investigational and 10 control subjects achieved the required imaging (x-rays and CT scan) at the 24-month timepoint.

Fusion Success is defined as \<5 degrees angulation, \<10% translation, and presence of bridging bone on CT.

Outcome measures

Outcome measures
Measure
Optimesh 1500S
n=77 Participants
OptiMesh 1500S, filled with a mixture of demineralized bone matrix (DBM) and cortico-cancellous bone, placed into the interbody space from the posterior approach and supplemental pedicle screws. OptiMesh 1500S: Following disc space preparation the OptiMesh is deployed and filled in accordance with study surgical technique and supplemental instrumentation is provided as an adjunct to fixation.
Structural Allograft Spacer
n=10 Participants
Structural Allograft Spacer with pedicle screws. Structural Allograft Spacer: Following disc space preparation the spacer is placed in accordance with cleared labeling and supplemental instrumentation is provided as an adjunct to fixation.
Number of Participants Determined to be a Fusion Success at 24 Months Post-operative
71 Participants
10 Participants

PRIMARY outcome

Timeframe: From Intra-op through the 24-month visit

The rate of serious device and procedure related adverse events are compared between the control and treatment arm from intraoperative through 24 months of follow-up.

Outcome measures

Outcome measures
Measure
Optimesh 1500S
n=123 Participants
OptiMesh 1500S, filled with a mixture of demineralized bone matrix (DBM) and cortico-cancellous bone, placed into the interbody space from the posterior approach and supplemental pedicle screws. OptiMesh 1500S: Following disc space preparation the OptiMesh is deployed and filled in accordance with study surgical technique and supplemental instrumentation is provided as an adjunct to fixation.
Structural Allograft Spacer
n=33 Participants
Structural Allograft Spacer with pedicle screws. Structural Allograft Spacer: Following disc space preparation the spacer is placed in accordance with cleared labeling and supplemental instrumentation is provided as an adjunct to fixation.
Number of Participants With a Serious Device and Procedure Related Adverse Event
14 Participants
6 Participants

SECONDARY outcome

Timeframe: 24-month visit

Population: A total of 78 investigational subjects and 16 control subjects reported right leg pain scores at pre-op and 24-months postoperative.

Right leg pain assessed by subject response on Visual Analog Scale (0-10 cm) where "0" represents "No pain" and "10" represents "Worst pain". The magnitude of change at 24-months compared to baseline is reported. A clinically relevant improvement is defined as a 2 cm reduction at 24-months compared to pre-op.

Outcome measures

Outcome measures
Measure
Optimesh 1500S
n=78 Participants
OptiMesh 1500S, filled with a mixture of demineralized bone matrix (DBM) and cortico-cancellous bone, placed into the interbody space from the posterior approach and supplemental pedicle screws. OptiMesh 1500S: Following disc space preparation the OptiMesh is deployed and filled in accordance with study surgical technique and supplemental instrumentation is provided as an adjunct to fixation.
Structural Allograft Spacer
n=16 Participants
Structural Allograft Spacer with pedicle screws. Structural Allograft Spacer: Following disc space preparation the spacer is placed in accordance with cleared labeling and supplemental instrumentation is provided as an adjunct to fixation.
Right Leg Pain Score--Change From Preop at the 24-month Timepoint
-2.6 units on a scale
Standard Error 0.4
-2.0 units on a scale
Standard Error 0.6

SECONDARY outcome

Timeframe: 24-month visit

Population: A total of 82 investigational subjects and 16 control subjects reported left leg pain scores at both pre-op and 24-months postoperative.

Left leg pain assessed by subject response on Visual Analog Scale (0-10cm) where "0" represents "No left leg pain" and "10" represents "Worst Pain". The magnitude of change at 24-months post-operative compared to the baseline score is reported. A clinically relevant improvement is defined as a 2 cm reduction at 24-months compared to pre-op.

Outcome measures

Outcome measures
Measure
Optimesh 1500S
n=82 Participants
OptiMesh 1500S, filled with a mixture of demineralized bone matrix (DBM) and cortico-cancellous bone, placed into the interbody space from the posterior approach and supplemental pedicle screws. OptiMesh 1500S: Following disc space preparation the OptiMesh is deployed and filled in accordance with study surgical technique and supplemental instrumentation is provided as an adjunct to fixation.
Structural Allograft Spacer
n=16 Participants
Structural Allograft Spacer with pedicle screws. Structural Allograft Spacer: Following disc space preparation the spacer is placed in accordance with cleared labeling and supplemental instrumentation is provided as an adjunct to fixation.
Left Leg Pain--Change From Preop at the 24-month Timepoint
-2.5 units on a scale
Standard Error 0.4
-2.5 units on a scale
Standard Error 0.8

SECONDARY outcome

Timeframe: 24-month visit

Population: Patient satisfaction was not obtained in the early portion of this study. Therefore, a total of 39 investigational subjects and 16 control subjects that were enrolled in the latter portion of the study contributed responses to this question.

Subjects were asked to rate their satisfaction with their surgical procedure as "Very Satisfied", "Somewhat Satisfied", "Somewhat Dissatisfied" or "Very Dissatisfied" with their procedure

Outcome measures

Outcome measures
Measure
Optimesh 1500S
n=39 Participants
OptiMesh 1500S, filled with a mixture of demineralized bone matrix (DBM) and cortico-cancellous bone, placed into the interbody space from the posterior approach and supplemental pedicle screws. OptiMesh 1500S: Following disc space preparation the OptiMesh is deployed and filled in accordance with study surgical technique and supplemental instrumentation is provided as an adjunct to fixation.
Structural Allograft Spacer
n=16 Participants
Structural Allograft Spacer with pedicle screws. Structural Allograft Spacer: Following disc space preparation the spacer is placed in accordance with cleared labeling and supplemental instrumentation is provided as an adjunct to fixation.
Number of Participants Rating Their Procedure as Very Satisfied or Somewhat Satisfied at 24-months Postoperative
37 Participants
13 Participants

Adverse Events

Optimesh 1500S

Serious events: 14 serious events
Other events: 19 other events
Deaths: 3 deaths

Structural Allograft Spacer

Serious events: 6 serious events
Other events: 6 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Optimesh 1500S
n=123 participants at risk
OptiMesh 1500S, filled with a mixture of demineralized bone matrix (DBM) and cortico-cancellous bone, placed into the interbody space from the posterior approach and supplemental pedicle screws. OptiMesh 1500S: Following disc space preparation the OptiMesh is deployed and filled in accordance with study surgical technique and supplemental instrumentation is provided as an adjunct to fixation.
Structural Allograft Spacer
n=33 participants at risk
Structural Allograft Spacer with pedicle screws. Structural Allograft Spacer: Following disc space preparation the spacer is placed in accordance with cleared labeling and supplemental instrumentation is provided as an adjunct to fixation.
Surgical and medical procedures
Hematoma
0.81%
1/123 • Number of events 1 • Intraoperative through 24-months postoperative
0.00%
0/33 • Intraoperative through 24-months postoperative
Surgical and medical procedures
Pseudoarthrosis
5.7%
7/123 • Number of events 9 • Intraoperative through 24-months postoperative
3.0%
1/33 • Number of events 1 • Intraoperative through 24-months postoperative
Surgical and medical procedures
Infection
1.6%
2/123 • Number of events 2 • Intraoperative through 24-months postoperative
3.0%
1/33 • Number of events 1 • Intraoperative through 24-months postoperative
Musculoskeletal and connective tissue disorders
Adjacent Level Degeneration
0.81%
1/123 • Number of events 1 • Intraoperative through 24-months postoperative
6.1%
2/33 • Number of events 2 • Intraoperative through 24-months postoperative
Surgical and medical procedures
Screw Irritation
2.4%
3/123 • Number of events 3 • Intraoperative through 24-months postoperative
0.00%
0/33 • Intraoperative through 24-months postoperative
Musculoskeletal and connective tissue disorders
Disc Herniation
100.0%
2/2 • Number of events 2 • Intraoperative through 24-months postoperative
3.0%
1/33 • Intraoperative through 24-months postoperative
Musculoskeletal and connective tissue disorders
Spinal Stenosis
0.00%
0/123 • Intraoperative through 24-months postoperative
6.1%
2/33 • Number of events 2 • Intraoperative through 24-months postoperative

Other adverse events

Other adverse events
Measure
Optimesh 1500S
n=123 participants at risk
OptiMesh 1500S, filled with a mixture of demineralized bone matrix (DBM) and cortico-cancellous bone, placed into the interbody space from the posterior approach and supplemental pedicle screws. OptiMesh 1500S: Following disc space preparation the OptiMesh is deployed and filled in accordance with study surgical technique and supplemental instrumentation is provided as an adjunct to fixation.
Structural Allograft Spacer
n=33 participants at risk
Structural Allograft Spacer with pedicle screws. Structural Allograft Spacer: Following disc space preparation the spacer is placed in accordance with cleared labeling and supplemental instrumentation is provided as an adjunct to fixation.
Surgical and medical procedures
Lateral femoral cutaneous nerve injury secondary to intra-op positioning on table
8.1%
10/123 • Number of events 10 • Intraoperative through 24-months postoperative
0.00%
0/33 • Intraoperative through 24-months postoperative
Musculoskeletal and connective tissue disorders
Low Back Pain
7.3%
9/123 • Number of events 9 • Intraoperative through 24-months postoperative
18.2%
6/33 • Number of events 6 • Intraoperative through 24-months postoperative

Additional Information

Rose Griffith, Sr. Director, Clinical Affairs

Spineology

Phone: 651-256-8503

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place